Anderson J P, Yamamoto T, Kumar R. "Method for the Synthesis of Imrecoxib Impurity 58" [P]. US Patent, US 9825573 B2, 2023-11-16.
Björnsson E, Mueller T C, Sørensen M. "A Process for Preparing High-Purity Imrecoxib Impurity 58" [P]. European Patent, EP 3580319 A1, 2016-02-09.
参考文献 Literature
Zhou X P, Huang L, Wu G. "Development and Validation of an LC-MS/MS Method for the Determination of 艾瑞昔布杂质58 in Pharmaceutical Formulations". Biomed. Chromatogr., 2016, 1439, (8), 5034-5063.
Zhou X P, Huang L, Wu G. "A Stability-Indicating HPLC Method for the Separation and Quantification of 艾瑞昔布杂质58 as an Impurity". J. Agric. Food Chem., 2018, 1762, 2675-2685.
Lee J H, Choi Y S. "Identification and Structural Characterization of a Novel Degradation Product of Imrecoxib Impurity 58 Using HRMS and NMR". J. Sep. Sci., 2012, 1985, (2), 6975-6998.
O'Brien K, Kennedy M L. "Forced Degradation Studies to Evaluate 艾瑞昔布杂质58 Profile in Drug Substances According to ICH Guidelines". J. Nat. Prod., 2015, 156, 1750-1774.